{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:07:42Z","timestamp":1790129262205,"version":"4.0.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>Inflammatory myofibroblastic tumor (IMT) of the female genital tract is under-recognized. We investigated the prevalence of ALK-positive IMT in lesions previously diagnosed as gynecologic smooth muscle tumors. Immunohistochemistry (IHC) for ALK was performed on tissue microarrays of unselected tumors resected from 2009 to 2013. Three of 1176 (0.26%) \u201cleiomyomas\u201d and 1 of 44 (2.3%) \u201cleiomyosarcomas\u201d were ALK IHC positive, confirmed translocated by fluorescence in situ hybridization (FISH) and therefore more appropriately classified as IMT. On review significant areas of all 4 tumors closely mimicked smooth muscle tumors morphologically, but all showed at least subtle\/focal features suggesting IMT. Recognizing that the distinction between IMT and leiomyoma\/leiomyosarcoma can be subtle, we then reviewed 1 hematoxylin and eosin slide from each patient undergoing surgery for \u201cleiomyoma\u201d from 2014 to 2017 and selected cases for ALK IHC with a low threshold. Of these, 30 of 571 (5.3%) underwent IHC. Two were confirmed to be IHC positive and FISH rearranged. Of the 6 IMTs, only 1 tumor with a previous diagnosis of leiomyosarcoma, an infiltrative margin and equivocal necrosis, metastasized. Of note it demonstrated a less aggressive clinical course compared with most metastatic leiomyosarcomas (alive with disease at 6 y). The patient was subsequently offered crizotinib to which she responded rapidly. In conclusion, IMTs may closely mimic gynecologic smooth muscle tumors. IMTs account for at least 5 of 1747 (0.3%) tumors previously diagnosed as leiomyoma and 1 of 44 (2.3%) as leiomyosarcoma. These tumors may be recognized prospectively with awareness of subtle\/focal histologic clues, coupled with a low threshold for ALK IHC.<\/jats:p>","DOI":"10.1097\/pas.0000000000000909","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T19:18:54Z","timestamp":1500664734000},"page":"1433-1442","source":"Crossref","is-referenced-by-count":75,"title":["Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized"],"prefix":"10.1097","volume":"41","author":[{"given":"Justine L.","family":"Pickett","sequence":"first","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Chou","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"The Kinghorn Cancer Centre and Garvan Institute of Medical Research, Darlinghurst, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana A.","family":"Andrici","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology, Royal North Shore Hospital"},{"name":"University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Clarkson","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"Sioson","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Sheen","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Reagh","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedaa","family":"Najdawi","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoomee","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, SYDPATH, St Vincent\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Riley","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, SYDPATH, St Vincent\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Maidens","sequence":"additional","affiliation":[{"name":"Gynaecological Oncology, Royal North Shore Hospital, St Leonards"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nevell","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"McIlroy","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Valmadre","sequence":"additional","affiliation":[{"name":"Gynaecological Oncology, Royal North Shore Hospital, St Leonards"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Gard","sequence":"additional","affiliation":[{"name":"Gynaecological Oncology, Royal North Shore Hospital, St Leonards"},{"name":"University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Hogg","sequence":"additional","affiliation":[{"name":"Gynaecological Oncology, Royal North Shore Hospital, St Leonards"},{"name":"University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Turchini","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology, Royal North Shore Hospital"},{"name":"University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Robertson","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, St George Hospital"},{"name":"University of NSW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Friedlander","sequence":"additional","affiliation":[{"name":"Prince of Wales Clinical School, University of New South Wales, Sydney"},{"name":"Department of Medical Oncology, Prince of Wales Hospital and Royal Hospital for Women, Randwick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology, Royal North Shore Hospital"},{"name":"University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jcp.2007.049387","article-title":"Inflammatory myofibroblastic tumours: where are we now?","volume":"61","author":"Gleason","year":"2008","journal-title":"J Clin Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/modpathol.2014.165","article-title":"Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors","volume":"28","author":"Hornick","year":"2015","journal-title":"Mod Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/modpathol.3880352","article-title":"ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor","volume":"14","author":"Coffin","year":"2001","journal-title":"Mod Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/PAS.0000000000000404","article-title":"Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement","volume":"39","author":"Antonescu","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0000000000000801","article-title":"Uterine inflammatory myofibroblastic tumors frequently harbour ALK fusions with IGFBP5 and THBS1","volume":"41","author":"Haimes","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/PAS.0000000000000677","article-title":"ETV6-NTRK3 is expressed in a subset of ALK-negative inflammatory myofibroblastic tumors","volume":"40","author":"Alassiri","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9440(10)61711-7","article-title":"Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor","volume":"159","author":"Bridge","year":"2001","journal-title":"Am J Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9440(10)64550-6","article-title":"TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors","volume":"157","author":"Lawrence","year":"2000","journal-title":"Am J Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/gcc.10177","article-title":"Fusion of ALK to the Ranbinding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor","volume":"37","author":"Ma","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","article-title":"Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions","volume":"4","author":"Lovly","year":"2014","journal-title":"Cancer Discov"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/PAT.0000000000000260","article-title":"Malignant inflammatory myofibroblastic tumour of the uterus","volume":"47","author":"Ak","year":"2015","journal-title":"Pathology"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa1007056","article-title":"Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor","volume":"363","author":"Butrynski","year":"2010","journal-title":"N Engl J Med"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(13)70095-0","article-title":"Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children\u2019s Oncology Group phase 1 consortium study","volume":"14","author":"Mosse","year":"2013","journal-title":"Lancet Oncol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/annonc\/mdw405","article-title":"Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib","volume":"27","author":"Mansfield","year":"2016","journal-title":"Ann Oncol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/MPH.0000000000000498","article-title":"Complete and repeated response of a metastatic ALK-rearranged inflammatory myofibroblastic tumor to crizotinib in a teenage girl","volume":"38","author":"Gaudichon","year":"2016","journal-title":"Pediatr Hematol Oncol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/his.12910","article-title":"ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours","volume":"69","author":"Yamamoto","year":"2016","journal-title":"Histopathology"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAT.0000000000000114","article-title":"Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer","volume":"46","author":"Houang","year":"2014","journal-title":"Pathology"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/01.pas.0000172189.02424.91","article-title":"Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors","volume":"29","author":"Rabban","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1440-1827.2006.02018.x","article-title":"Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change","volume":"56","author":"Shintaku","year":"2006","journal-title":"Pathol Int"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1067\/S0002-9378(03)00208-4","article-title":"Inflammatory myoblastic tumor of the uterus and interleukin-6","volume":"189","author":"Azuno","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejogrb.2011.02.016","article-title":"Hysteroscopic excision of inflammatory myofibroblastic tumor of the uterus: a case report and brief review","volume":"157","author":"Olgan","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/PAS.0000000000000330","article-title":"Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course","volume":"39","author":"Parra-Herran","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.gynor.2013.07.007","article-title":"Extrauterine inflammatory myofibroblastic tumor: a case report","volume":"6","author":"Kushnir","year":"2013","journal-title":"Gynecol Oncol Case Rep"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1200\/JCO.2013.48.8304","article-title":"Uterine inflammatory myofibroblastic tumor in a 10-year-old girl presenting as polypoid mass","volume":"33","author":"Fraggetta","year":"2015","journal-title":"J Clin Oncol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13045-015-0160-2","article-title":"STUMP un\u201cstumped\u201d: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion","volume":"8","author":"Subbiah","year":"2015","journal-title":"J Hematol Oncol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAS.0000000000000593","article-title":"Myxoid leiomyosarcoma of the uterus: a clinicopathologic analysis of 30 cases and review of the literature with reappraisal of its distinction from other uterine myxoid mesenchymal neoplasms","volume":"40","author":"Parra-Herran","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings","volume":"40","author":"Harrison","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/his.13176","article-title":"Abnormal p53 and p16 staining patters distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour","volume":"70","author":"Schaefer","year":"2017","journal-title":"Histopathology"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ajcp\/94.4.435","article-title":"The frequency of uterine leiomyomas","volume":"94","author":"Cramer","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/JTO.0b013e31820b82e8","article-title":"Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization","volume":"6","author":"Paik","year":"2011","journal-title":"J Thorac Oncol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/PAS.0000000000000368","article-title":"A detailed clinicopathological study of alk translocated papillary thyroid carcinoma","volume":"39","author":"Chou","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/JTO.0b013e318274a83e","article-title":"Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent","volume":"8","author":"Conklin","year":"2013","journal-title":"J Thorac Oncol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/modpathol.2013.87","article-title":"Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization","volume":"26","author":"Selinger","year":"2013","journal-title":"Mod Pathol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/PAS.0b013e318200cfd5","article-title":"Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK","volume":"35","author":"Marino-Enriquez","year":"2011","journal-title":"Am J Sug Pathol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/01.MP.0000026615.04130.1F","article-title":"Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases","volume":"15","author":"Cessna","year":"2002","journal-title":"Mod Pathol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.humpath.2003.12.004","article-title":"Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases","volume":"35","author":"Li","year":"2004","journal-title":"Hum Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201710000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:27:16Z","timestamp":1695407236000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201710000-00014"}},"subtitle":["A Low Threshold for ALK Immunohistochemistry Is Required"],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000909","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727824748.793593446","asserted-by":"object"}]},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}